The roadmap for WHO action 2025–2030 outlines to Member States, and other stakeholders WHO’s unique role and approach for increasing access...
The non‐medical use of opioids, both medicines and synthetic substances, is an increasing concern for ...
In January 2010, the Executive Board of the World Health Organization's (WHO) adopted a revision of the Guidelines for The WHO Review of Psychoactive...
15 June 2023
Left behind in pain: Extent and causes of global variations in access to morphine for medical use and...
Morphine is an essential medicine for relieving moderate to severe pain. It is also essential for treating severe breathlessness that is refractory to...
13 October 2025
Opioid agonist maintenance treatment as an essential health service: implementation guidance on mitigating...
Opioid agonist maintenance treatment (OAMT) for people with opioid dependence is proven to be safe and effective in addressing a broad range of health...